Physician profile
Chad M Gorman
NPI 1659507507
$41,538.12
in general payments reported to CMS, 2019-2025
51 companies · $11K in 2025
The $11K reported for 2025 was more than what 98% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,389 · 2020: $2,366 · 2021: $3,056 · 2022: $7,435 · 2023: $6,818 · 2024: $8,819 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Travel and Lodging: $5,869 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,290 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,682.75 |
| Travel and Lodging | $5,869.42 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,290.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $23,495.62 | 2019-2025 | Proclaim, Eterna, Axium |
| Nutech Spine, INC. | $4,846.78 | 2020-2022 | |
| Collegium Pharmaceutical, INC. | $1,555.07 | 2019-2025 | Xtampza, Belbuca |
| Medtronic, INC. | $1,536.73 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Rialto Si Fusion System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,412.42 | 2019-2025 | Relistor |
| Abbvie INC. | $1,283.84 | 2021-2025 | |
| Scilex Pharmaceuticals INC. | $711.68 | 2019-2025 | Ztlido |
| Nevro Corp. | $669.84 | 2019-2024 | Senza |
| Pfizer INC. | $609.78 | 2019-2025 | |
| Boston Scientific Corporation | $582.02 | 2022-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Biodelivery Sciences International, INC. | $474.21 | 2019-2021 | |
| Foundation Fusion Solutions, LLC | $436.67 | 2025 | |
| Medtronic USA, INC. | $424.96 | 2019-2020 | |
| Lilly USA, LLC | $339.01 | 2019-2024 | Emgality, Reyvow |
| Flowonix Medical Incorporated | $334.06 | 2019-2020 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Gorman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.